Twin Tree Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $444K | Buy |
+2,097
| New | +$412K | 0.01% | 1050 |
|
|
2025
Q4 | – | Sell |
-2,850
| Closed | -$543K | – | 1485 |
|
|
2025
Q3 | $543K | Sell |
2,850
-7,701
| -73% | -$1.37M | ﹤0.01% | 1272 |
|
|
2025
Q2 | $1.9M | Buy |
+10,551
| New | +$1.83M | ﹤0.01% | 1266 |
|
|
2024
Q4 | – | Sell |
-54
| Closed | -$8.38K | – | 1638 |
|
|
2024
Q3 | $8.38K | Sell |
54
-10,314
| -99% | -$1.54M | ﹤0.01% | 1447 |
|
|
2024
Q2 | $1.42M | Buy |
10,368
+8,131
| +363% | +$1.11M | ﹤0.01% | 1016 |
|
|
2024
Q1 | $298K | Buy |
+2,237
| New | +$290K | ﹤0.01% | 1133 |
|
|
2022
Q1 | – | Sell |
-169,794
| Closed | -$29.4M | – | 1677 |
|
|
2021
Q4 | $29.4M | Buy |
+169,794
| New | +$25.8M | 0.06% | 298 |
|
|
2021
Q1 | – | Sell |
-754
| Closed | -$90K | – | 1399 |
|
|
2020
Q4 | $90K | Buy |
+754
| New | +$91.9K | ﹤0.01% | 1137 |
|
|
2020
Q3 | – | Sell |
-138,176
| Closed | -$15.7M | – | 1299 |
|
|
2020
Q2 | $15.7M | Buy |
138,176
+128,627
| +1,347% | +$13.6M | 0.06% | 335 |
|
|
2020
Q1 | $767K | Buy |
9,549
+1,684
| +21% | +$174K | ﹤0.01% | 910 |
|
|
2019
Q4 | $840K | Buy |
+7,865
| New | +$820K | ﹤0.01% | 884 |
|
|
2019
Q2 | – | Sell |
-1,428
| Closed | -$128K | – | 1296 |
|
|
2019
Q1 | $128K | Buy |
1,428
+1,124
| +370% | +$97.4K | ﹤0.01% | 1072 |
|
|
2018
Q4 | $25K | Buy |
+304
| New | +$28.5K | ﹤0.01% | 1166 |
|
|
2018
Q3 | – | Sell |
-10,456
| Closed | -$1.15M | – | 1098 |
|
|
2018
Q2 | $1.15M | Buy |
10,456
+5,691
| +119% | +$593K | 0.01% | 757 |
|
|
2018
Q1 | $478K | Buy |
4,765
+4,757
| +59,463% | +$487K | ﹤0.01% | 796 |
|
|
2017
Q4 | $1K | Sell |
8
-1,139
| -99% | -$108K | ﹤0.01% | 982 |
|
|
2017
Q3 | $107K | Buy |
+1,147
| New | +$122K | ﹤0.01% | 864 |
|
|
2017
Q2 | – | Sell |
-16,705
| Closed | -$1.64M | – | 986 |
|
|
2017
Q1 | $1.64M | Buy |
+16,705
| New | +$1.59M | 0.01% | 608 |
|
|
2016
Q3 | – | Sell |
-13,015
| Closed | -$1.06M | – | 1179 |
|
|
2016
Q2 | $1.06M | Buy |
13,015
+12,155
| +1,413% | +$926K | 0.02% | 649 |
|
|
2016
Q1 | $61K | Buy |
+860
| New | +$57.7K | ﹤0.01% | 1124 |
|
|
2015
Q3 | – | Sell |
-1,599
| Closed | -$112K | – | 1351 |
|
|
2015
Q2 | $116K | Sell |
1,599
-9,534
| -86% | -$704K | ﹤0.01% | 1139 |
|
|
2015
Q1 | $856K | Buy |
+11,133
| New | +$797K | 0.02% | 641 |
|
Other funds holding DGX
EIG
Twin Tree Management's DGX Position: Q2 2026 in Review
Twin Tree Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 2,097 shares worth $444K. The stake represents 0.01% of the portfolio and ranks #1050 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in DGX as recently as Q3 2025.
Twin Tree Management first reported a position in DGX in Q1 2015 and has held it in 22 quarters since. The position peaked at $29.4M in Q4 2021. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Twin Tree Management held 2,097 shares of Quest Diagnostics worth $444K as of Q2 2026.
- Quest Diagnostics was a new Twin Tree Management position in Q2 2026.
- Quest Diagnostics made up 0.01% of Twin Tree Management's portfolio in Q2 2026, its #1050 holding.
- Twin Tree Management first reported a position in Quest Diagnostics in Q1 2015 and has held it in 22 quarters since.
- Twin Tree Management's Quest Diagnostics position peaked at $29.4M in Q4 2021.
- 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Twin Tree Management's 13F filing for Q2 2026, filed 12 Aug 2026.